[1]
R. Müller, C. Renner, C. Gabay, G. Cassata, A. Lohri, and P. Hasler, “The advent of biosimilars: challenges and risks”, Swiss Med Wkly, vol. 144, no. 2728, p. w13980, Jun. 2014.